Events at UNC Lineberger Comprehensive Cancer Center
Use filters to sort and view events from one of the categories.
- This event has passed.
3rd Annual Christopher Perri Memorial Symposium
Join us for the 3rd Annual Christopher Perri Memorial Symposium discussing topics of high impact and interest in acute myeloid leukemia (AML).
The event will be held at the Carolina Inn in Chapel Hill, NC. Food and refreshments will be served. Please see the agenda below for event details.
Registration is now open. The event is free to all academic and clinical partners. There will be a fee for industry personnel.
For event questions, please contact Susan Ferguson, susan.ferguson@med.unc.edu
Special thanks to this year’s sponsors:
8 a.m. — Network, Coffee
8:30 a.m. — Welcome and Introduction: “Remembering Chris Perri”
Laura Blanchard, MPAP, PA-C
8:45 a.m. — Remarks from Dona Zino, Inspiring Story of Resilience and Perseverance
9 a.m. — LEAP Program Highlights
Robyn Tolley, MSN, AGPCNP-BC
9:15 a.m. — “Leukemia Clinical Research Program: Building Success Through Growth and Teamwork”
Allison McKinney, CCRP
9:30 a.m. — “De-Intensifying Frontline Therapy for AML”
Brittany Ragon, MD, assistant professor; leukemia and transplant specialist, Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute
10:15 a.m. — Break: Network, Snacks, Coffee
10:30 a.m. — “Optimizing Frontline Management of FLT3-Mutated AML”
Harry Erba, MD, PhD, professor of medicine, Duke University School of Medicine; director, Leukemia Program, Duke Cancer Institute
11:15 a.m. — “Biology and Management of TP53-Mutated AML”
David Sallman, MD, assistant member, Department of Malignant Hematology, Moffitt Cancer Center
12 – 1 p.m. — Lunch and networking
1 p.m. — Remarks from Dr. Raymond Yang, Inspiring Story of Hope and Promise of Clinical Trials for AML
1:15 p.m. — “Menin Inhibitors in AML: Hitting the Target in NPM1 and KMT2A Alterations”
Joshua Zeidner, MD, associate professor of medicine, UNC School of Medicine; chief of leukemia research, UNC Lineberger Comprehensive Cancer Center
2 p.m. — Keynote Speaker: “Early Intervention in Patients with Clonal Hematopoiesis and Increased Risk for Myeloid Malignancies”
Uma Borate, MBBS, associate professor, Division of Hematology, The Ohio State University; clinical research director, acute leukemia, The Ohio State University Comprehensive Cancer Center – James
2:45 – 3 p.m. — Closing remarks
